UnknownNot Applicable

Evaluation of Patients With Diffuse Parenchymal Lung Diseases Regarding Frailty

Turkey (Türkiye)28 participantsStarted 2023-12-25

Plain-language summary

There are very few studies in the literature examining the frailty levels of diffuse parenchymal lung disease (DPLD) patients and its effect on their functional status despite the high prevalance of frailty in patients with DPLD This observational study aims to learn about the relationship between frailty and functional capacity and balance in DPLD patients compared to healthy subjects.

Who can participate

Age range

30 Years – 65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Being diagnosed with Diffuse parenchymal lung according to the American Thoracic Society/European Respiratory Society (ATS/ERS) criteria, * Being between the ages of 30-65, * Being literate, * Being willing to participate in the research, * Being clinically stable and having any accompanying comorbid conditions (such as hypertension, diabetes) under control, * Not having any orthopedic, metabolic or neurological problems that may prevent evaluation of peripheral muscle strength, balance and exercise capacity. Exclusion Criteria: * Having recently experienced syncope, * Having a history of unstable cardiovascular disease, * Having been hospitalized due to exacerbation in the last 3 months, * Having received pulmonary rehabilitation in the last 12 months, * Having a neurological disease, * Being dependent and using a walking aid while performing the person's daily life activities, * Having a pacemaker, * Having a diagnosis of lung cancer

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

frailty level

Timeframe: 1 time which will be in one day

Trial details

NCT IDNCT06171425

SponsorHacettepe University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-01-01

Contact for this trial

AYNUR DEMIREL, Assoc. Prof.

+9053123051576 aynur.demirel@hacettepe.edu.tr

View on ClinicalTrials.gov More Diffuse Parenchymal Lung Disease trials